1. Market Research
Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018

Burkholderia pseudomallei Infection Drug Development Pipeline Study, H2 2018

  • August 2018
  • 45 pages
  • ID: 5483449
  • Format: PDF
  • By VPAResearch

Summary

Table of Contents

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies

Burkholderia (Melioidosis) Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Burkholderia pipeline products.

DISEASE OVERVIEW
Increase in prevalence of lung diseases is one of the main drivers behind the growth in Burkholderia (Melioidosis) Infections disease. South East Asian countries and Pacific nations are largely affected by the disease. Tropical and developing countries in Sub Saharan African and Latin American regions are also witnessing melioidosis.

Around 0.2 million patients are affected with the melioidosis disease and around half of the patients witness mortality. Poor diagnosis is the main challenge in detecting and treating Burkholderia Infections disease.

Individuals with low immunity levels and patients suffering from renal, lung and liver diseases are more susceptible to be affected by the highly pathogenic bacterium. Presence of the bacteria is detected through laboratory diagnosis of blood or urine or sputum.

Exposure to soil or water contaminated with these bacteria is the primary cause for occurrence of melioidosis.

Nine companies are actively developing therapeutic compounds for treatment of Melioidosis Infections. A total of 10 therapeutic candidates are being developed which include vaccines such as MVA-BN Vaccine and Syntiron Vaccines.

Companies actively investing their resources in Burkholderia Infection pipeline include- AlgiPharma AS, Bavarian Nordic A/S, Emergent BioSolutions Inc, Forge Therapeutics Inc, Grifols SA, MerLion Pharmaceuticals Pte Ltd, Soligenix Inc, Syntiron LLC and VenatoRx Pharmaceuticals.

REPORT DESCRIPTION
The Burkholderia pipeline guide presents complete overview of drugs currently being developed for Burkholderia. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Burkholderia pipeline candidate.
Research and Development progress along with latest news related to each of the Burkholderia pipeline candidates is included.

Major companies participating in therapeutic development of Burkholderia are included in this pipeline report. Company wise pre-clinical and clinical products along with details of drug originator, co-developers/ licensors are provided.

Amid strong interest for cure of Burkholderia from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Burkholderia clinical and pre-clinical products.

The report assists in identifying potential upcoming companies and drugs in Burkholderia pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.

Scope of Burkholderia pipeline report includes
- Panorama of Burkholderia pipeline markets including statistics on therapeutic drugs and companies involved

- Burkholderia Pipeline candidates across various development phases including both pre-clinical, discovery and clinical stages are covered

- Burkholderia pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study

- Overview of companies participating in Burkholderia pipeline with short introduction to their businesses and pipeline projects

- For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co-developer and licensee are provided.

- Research and Development progress and trial details, results wherever available, are also included in the pipeline study

- The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Burkholderia pipeline therapeutics

Reasons to Buy
- Get clear understanding of the entire Burkholderia pipeline, with details on active projects

- Get in detail information of each product with updated information on each project along with key milestones

- Know the list of companies participating in global Burkholderia pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data

- Get trial information for each pipeline product under development

- Understand the pipeline structure in terms of mechanism of Action, phase and company

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Spirometers Market- Growth, Trends, and Forecast (2020 - 2025)

  • $ 4250
  • March 2020
  • 105 pages

The spirometers market will show rapid growth due to the rise in the prevalence of chronic obstructive pulmonary disease (COPD), technological advancements in the field of spirometers and growing preference ...


ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on